Myogenesis is the process by which muscle tissue is formed during embryonic development and throughout postnatal life. It involves a series of coordinated events, including the specification of muscle precursor cells, their proliferation, migration, differentiation, and fusion to form multinucleated myotubes, which ultimately mature into functional muscle fibres. During embryonic development, myogenesis begins with the specification of mesodermal cells in the somites to become myogenic precursor cells, known as myoblasts. These myoblasts express specific transcription factors, such as MyoD, Myf5, Myogenin, and MRF4, which regulate their commitment to the muscle lineage and initiate the expression of muscle-specific genes. As development progresses, myoblasts proliferate and migrate to their final destinations within the embryo, guided by various signalling molecules and cell-cell interactions. Upon reaching their target locations, myoblasts exit the cell cycle and undergo terminal differentiation, characterized by the expression of contractile proteins such as myosin and actin, and the formation of sarcomeres—the basic functional units of muscle contraction. In summary, myogenesis is a complex and tightly regulated process that governs the formation, growth, and regeneration of muscle tissue. By unraveling the molecular and cellular mechanisms underlying myogenesis, researchers can gain insights into muscle development and function and develop new strategies for treating muscle-related disorders and promoting musculoskeletal health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy